LAMP3 deficiency affects surfactant homeostasis in mice

Abstract

Lysosome-associated membrane glycoprotein 3 (LAMP3) is a type I transmembrane protein of the LAMP protein family with a cell-type-specific expression in alveolar type II cells in mice and hitherto unknown function. In type II pneumocytes, LAMP3 is localized in lamellar bodies, secretory organelles releasing pulmonary surfactant into the extracellular space to lower surface tension at the air/liquid interface. The physiological function of LAMP3, however, remains enigmatic. We generated Lamp3 knockout mice by CRISPR/Cas9. LAMP3 deficient mice are viable with an average life span and display regular lung function under basal conditions. The levels of a major hydrophobic protein component of pulmonary surfactant, SP-C, are strongly increased in the lung of Lamp3 knockout mice, and the lipid composition of the bronchoalveolar lavage shows mild but significant changes, resulting in alterations in surfactant functionality. In ovalbumin-induced experimental allergic asthma, the changes in lipid composition are aggravated, and LAMP3-deficient mice exert an increased airway resistance. Our data suggest a critical role of LAMP3 in the regulation of pulmonary surfactant homeostasis and normal lung function.

Introduction

The lysosome-associated membrane glycoprotein (LAMP) family consists of five members (LAMP1, LAMP2, LAMP3 / DC-LAMP, CD68 / macrosialin, and LAMP5 (BAD-LAMP)). All family members are heavily N- and O-glycosylated type I transmembrane proteins localized to the limiting membrane of lysosomes and lysosome-related organelles [1]. LAMP1 and LAMP2 are ubiquitously expressed [1], while LAMP3 (synonymously called DC-LAMP), CD68, and LAMP5 show cell-type-specific or tissue-specific expression. CD68 expression is restricted to macrophages, monocytes, and microglia [2], whereas LAMP5 is expressed exclusively in the brain [3]. The LAMP3-expression pattern between humans and mice differs: LAMP3 is expressed in humans in alveolar type II (AT2) cells and dendritic cells (DC) (eponymously for its alternative name "DC-LAMP" or CD208). In mice,LAMP3 is found exclusively in AT2 cells but not in DCs [4–7]. These findings suggest a conserved and critical function of LAMP3 in AT2 cells. On the subcellular levels, LAMP3 is localized in lamellar bodies (LBs) [4]. However, the function of LAMP3 in these cells remains enigmatic until now; if and how LAMP3 affects surfactant homeostasis, e.g., mediating surfactant release via LBs, is also poorly understood.

The primary function of AT2 cells is mainly attributed to pulmonary surfactant release to lower surface tension at the lung’s air/liquid interface. Pulmonary surfactant is a mixture of lipids and proteins [8]: The major hydrophobic protein components, surfactant proteins B (SP-B) and C (SP-C), are small proteins deeply embedded into the phospholipids of the surfactant. Notably, deficiency in SP-B or SP-C due to genetic mutations in SFTPB or SFTPC cause hereditary forms of childhood interstitial lung disease [9,10]. Sftpb gene-targeted mice die of respiratory failure after birth, associated with irregular and dysfunctional LBs and tubular myelin [11]. SP-C deficient mice have a regular life span and only show subtle deficits in lung mechanics and surfactant stability [12].

The composition of surfactant lipids has been analyzed extensively [13–17]. The most abundant and characteristic lipid class is phosphatidylcholine (PC). PC makes up approximately 70% of the total surfactant mass with dipalmitoylphosphatidylcholine (DPPC; PC 16:0/16:0) as the primary lipid species [18]. An overall decrease of PC lipids is coupled to higher surface tension and lower surfactant protein inclusion [8]. Other highly abundant and functionally essential phospholipid classes in surfactant include phosphatidylglycerol (PG) and phosphatidylinositol (PI), while phosphatidylethanolamine (PE), and sphingomyelin (SM) are reported as minor components of surfactant and most likely derived from other cell membranes. In addition, lysophosphatidylcholine (LPC) can be found in low abundance in pulmonary surfactant [18,19]. Preassembled surfactant is stored in secretory organelles known as LB that fuse with the cell membranes and release pulmonary surfactant. LBs are multivesicular body / late endosome-derived specialized organelles filled with surfactant characterized by a typical "myelin"-like appearance by electron microscopy. Phospholipids are directly transferred from the endoplasmic reticulum to LB through a vesicle-independent mechanism by the phospholipid transporter "ATP binding cassette subfamily A member 3" (ABCA3) [20,21]. Like SFTPB or SFTPC, loss-of-function mutations in ABCA3 were identified in full-term infants who died from unexplained fatal respiratory distress syndrome [22]. ABCA3 mutations represent the most frequent form of congenital surfactant deficiencies [23].

A presumably loss-of-function mutation in LAMP3 (p.(E387K)) was recently identified in an Airedale Terrier dog breed, leading to severe symptoms and pathology similar to clinical symptoms of the most severe neonatal forms of human surfactant deficiency [24]. The affected puppies’ symptoms included lethal hypoxic respiratory distress and occurred within the first days or weeks of life [24]. LBs were smaller, contained fewer lamellae, and occasionally revealed a disrupted common limiting membrane [24].

To conclusively address the physiological role of LAMP3 in surfactant homeostasis using a genetically defined animal model, we generated Lamp3 knockout mice (KO, Lamp3-/-) by CRISPR/Cas9. In contrast to dogs bearing a natural mutation in LAMP3, Lamp3-/- mice are vital, display a regular lung function at the basal level, and show no increased prenatal lethality. The lungs of Lamp3-/- animals did neither macroscopically nor microscopically differ from those of wild type littermates. However, biochemical analysis of broncho-alveolar lavage (BAL) fluid clearly revealed increased pro-SP-C levels and altered lipid composition in the Lamp3-/- mice. These differences are further pronounced under diseased conditions as evoked by allergen-induced experimental asthma, and most notably, diseased Lamp3-/- mice revealed significantly increased airway resistance, when stressed during methacholine provocation testing. In conclusion, our data suggest a critical but not essential role of LAMP3 in pulmonary surfactant homeostasis associated with normal lung function.

Material & methods

Ethical statement

All animal studies were approved by the local animal ethics committe (Ministerium für Energiewende, Landwirtschaft, Umwelt, Natur und Digitalisierung; AZ V242-4255/2018, and V244-2826/2017 (32-3/17)).

Reagents and antibodies

Analytical grade chemicals were purchased, if not stated otherwise, from Sigma-Aldrich (MO., USA). Antibodies: The following antibodies were used in the study: Rat monoclonal LAMP3, clone 1006F7.05 (Dendritics), SP-C, rabbit polyclonal (Abcam), rabbit polyclonal antibodies against mature SP-B and Pro-SP-B (Seven Hills Bioreagents) were a generous gift from Jeffrey A. Whitsett, polyclonal β-Actin (Santa Cruz Biotechnology, Inc), polyclonal rabbit antiserum against ABCA3 was a kind gift from Michael L. Fitzgerald [20]. Fluorophore-conjugated secondary antibodies against the corresponding primary antibody species (AlexaFluor 488) were purchased from Invitrogen / Molecular Probes and were diluted 1:500.

Generation and housing of Lamp3-/- mice

Mice with a null mutation in the Lamp3 gene were generated in a C57BL/6N background using a CRISPR genome-editing system. For this purpose, Cas9 was combined with two single guide RNAs (sgRNAs) targeting the second exon in the Lamp3 gene with the following spacer sequences: sgRNA_Lamp3 F1: TCATCTACTGACGATACCAT and sgRNA_Lamp3 R1: GCTAGACTAGCTCTGGTTGT microinjected into fertilized zygotes. Genome editing was confirmed by PCR amplification in the resulting founder mice with the primers Lamp3F 5´-GATGGGGGAGGGATCTTTTA-3’ and Lamp3R 5´-GTTGGCCTCTGATTGGTTGT-3’. A founder harboring a 40 bp deletion within the second exon leading to a frameshift mutation was selected for further breeding. Mice were housed under specific pathogen-free conditions (12 hours’ light/dark cycle, constant room temperature, and humidity). Food and water were available ad libitum.

Ovalbumin model of allergic asthma

Female, 6- to 8-week-old Lamp3-/- and wildtype littermates mice (CAU, Kiel, Germany) were used for the allergic asthma model. They received ovalbumin (OVA)-free diet and water ad libitum.

Mice were sensitized to OVA by three intraperitoneal (i.p.) injections of 10 μg of OVA (OVA grade VI, Sigma-Aldrich, St. Louis, MO, USA) adsorbed to 150 μg of aluminum hydroxide (imject alum, Thermo Fisher Scientific, Waltham, MA, USA) on days 1, 14 and 21. To induce acute allergic airway inflammation, mice were exposed three times to an OVA (OVA grade V, Sigma-Aldrich) aerosol (1% wt/vol in PBS) on days 26, 27, and 28. Control animals were sham sensitized to PBS and subsequently challenged with OVA aerosol.

Lung function analysis

Steady-state lung parameters midexpiratory flow (EF50), frequency (f), functional residual capacity (Frc), minute volume (MV), peak expiratory flow (PEF), peak inspiratory flow (PIF), expiration time (Te), inspiration time (Ti), and tidal volume (TV) were measured in conscious, spontaneously breathing mice using FinePointe non-invasive airway mechanics double-chamber plethysmography (NAM, Data Science International, St. Paul, MN, USA). Steady-state airway resistance (RI) and dynamic compliance (Cdyn) were measured in anesthetized and ventilated mice using FinePointe RC Units (Data Science International). Airway responsiveness to methacholine (MCh, acetyl-β-methylcholine chloride; Sigma-Aldrich) challenge was invasively assessed on day 29 using FinePointe RC Units (Data Science International, St. Paul, MN, USA) by continuous measurement of RI. Animals were anesthetized with ketamine (90 mg/kg body weight; cp-pharma) and xylazine (10 mg/kg BW; cp-pharma) and tracheotomized with a cannula. Mechanical ventilation was previously described [25]. Measurements were taken at baseline (PBS) and in response to inhalation of increased concentrations of aerosolized methacholine (3.125; 6.25; 12.5; 25; 50; and 100 mg/mL). After assessment of lung function, all animals were sacrificed by cervical dislocation under deep anesthesia.

Bronchoalveolar lavage

For bronchoalveolar lavage, lungs were rinsed with 1 ml of fresh, ice-cold PBS containing protease inhibitor (Complete, Roche, Basel, Switzerland) via a tracheal cannula. Cells in BAL fluid were counted in the Neubauer chamber. Fifty microliter aliquots of lavage fluids were subjected to centrifugation (5 minutes at 320 g) (Zytozentrifuge Shandon Cytospin 4, Thermo Fisher Scientific), and cells were microscopically differentiated according to morphologic criteria.

Electron microscopy

Animals were anesthetized and lungs were fixed by perfusion through the right ventricle with HEPES buffer (pH 7.35) containing 1.5% glutaraldehyde and 1.5% formaldehyde, at a fixed positive inflation pressure of 25 cm H2O. After storage of the lungs in the same solution overnight, 3 mm sized pieces of lung tissue were postfixed first in 1% osmium tetroxide for 2 hours and then in 4% uranyl acetate overnight (both aqueous solutions). Samples were dehydrated in acetone and embedded in Epon. Ultrathin sections of 60 nm were poststained with aqueous uranyl acetate and lead citrate [26] and imaged in a Morgagni TEM (FEI, Eindhoven, NL).

Histology

Lungs were dissected from mice, and the left lung lobe was snap-frozen in liquid nitrogen. The other lobes were fixed ex-situ with 4% (wt/vol) formaldehyde via the trachea under constant pressure, removed and stored in 4% formaldehyde. Volume of these lobes was determined based on Archimedes’ principle. In brief, the remaining lung lobes were placed in a water-filled container set on electronic scales. The weight of water displaced by the submerged lung equals the volume of the lung. Then lung tissues were embedded in paraffin. For analysis of lung inflammation, 2 μm sections were stained with periodic acid-Schiff (PAS). Photomicrographs were recorded by a digital camera (DP-25, Olympus, Tokyo, Japan) attached to a microscope (BX-51, Olympus) with a 20-fold magnification objective using Olympus cell^A software. Mucus quantification was performed as previously described [27]. Apoptotic cells were stained using ApopTag Peroxidase In Situ Apoptosis Detection Kit (Merck Millipore, MA, USA) according to manufacturer’s instructions.

Immunofluorescence staining of lung tissue

4% Formaldehyde-fixed lungs were incubated in cryoprotectant solution (30% w/v sucrose in 0.1 M phosphate buffer, pH 7.4) over night. 35 μm thin sections were cut with a Leica 9000s sliding microtome (Leica, Wetzlar, Germany) and collected in cold 0.1 M phosphate buffer (PB). Free floating sections were stained by blocking in blocking solution (0.5% Triton-X 100, 4% normal goat serum in 0.1 M PB pH 7.4) for 1 hour at room temperature. Subsequently, sections were incubated in blocking solution containing the primary antibody at 4°C over night. After washing three times with wash solution (0.1 M PB pH 7.4 containing 0.25% Triton-X 100), sections were incubated for 2 hours in secondary antibody in solution, washed again three times in wash solution containing 4′,6-Diamidin-2-phenylindol (DAPI) and finally brought on glass slides and embedded in Mowiol/DABCO. Cells were imaged using a Zeiss confocal microscope equipoped with a 63x objective (Zeiss LSM980 AiryScan 2).

Homogenization of lung tissue

Deep frozen lungs were homogenized with mortar and pestle. An aliquot of 30 mg of lung powder was transferred into RLT buffer (Qiagen), and RNA was isolated with RNeasy Mini Kit (Qiagen) according to the manufacturer’s guidelines. 1 μg of RNA was used for cDNA synthesis (First Strand cDNA Synthesis Kit, Thermo Fisher Scientific, Waltham, MA, USA). Another 30 mg aliquot of lung powder was transferred into radioimmunoprecipitation assay buffer (RIPA) buffer, and proteins were isolated. Protein concentration was determined by bicinchoninic acid (BCA) assay (Thermo Fisher Scientific, Waltham, MA, USA).

Immunoblot analysis

Western analysis was performed on lung tissue homogenates from wildtype and LAMP3-deficient mice. Protein content was measured by the BCA assay (Thermo Fisher Scientific, Waltham, MA, USA). Defined amounts of protein were separated on SDS-PAGE and transferred to nitrocellulose membrane. Membranes were incubated with anti-pro-SP-C (rabbit monoclonal, 1:1000, Abcam, Cambridge, UK), anti-pro-SP-B (rabbit polyclonal, 1:2000, Seven Hills Bioreagents, CA, USA), anti-mature SP-B (rabbit polyclonal, 1:1000, Seven Hills Bioreagents), and anti-β-actin (mouse monoclonal, 1:200, Santa Cruz Biotechnology, Heidelberg, Germany). Donkey anti-rabbit IgG HRP (1:2000, Santa Cruz) and donkey anti-mouse IgG HRP (1:2000, Cell Signaling) served as secondary antibodies Immunoreactive proteins were visualized using the ECL Western blotting detection system (Bio-Rad Laboratories GmbH, Feldkirchen, Germany), band intensity was quantified with Image J 1.52 (NIH), and data were normalized to β-actin levels.

Quantitative PCR

Quantitative RT-PCR was performed on the Roche LightCycler 480 Instrument II system using the LightCycler 480 SYBR Green I Master (Roche Applied Science, Mannheim, Germany). Template cDNA was diluted 1:10. RT-PCR was performed in triplicate in a total volume of 10 μl according to the manufacturer’s instruction with a final primer concentration of 0.5 μM. Cycling conditions were as follows: 45 cycles at 95°C for 10 s, touch-down annealing temperature (63 to 58°C, temperature reduction 0.5°C per cycle) for 10 s and 72°C for 8 s. For each primer pair, a standard curve was established by serial cDNA dilutions. The following primer sequences for reference gene RPL32 were used: forward 5‘-AAAATTAAGCGAAACTGGCG-3’, reverse 5‘-ATTGTGGACCAGGAACTTGC-3’ (NM_172086.2,156 bp). QuantiTect Primer Assays from Qiagen (Venlo, The Netherlands) were used for Lamp3 (QT00157031, NM_177356, 105 bp), Sftpb (QT00124908, NM_011359, 125 bp) and Sftpc (QT00109424, NM_011359, 125 bp). Negative controls (reverse transcriptase/RNA template) were included to detect possible contaminations. Amplification specificity was checked using the melting curve and agarose gel (2%) electrophoreses with a Gene Ruler 50bp DNA ladder (Thermo Scientific). Specific mRNA levels were normalized to the level of the reference gene Rpl32 in the same sample. Data were analyzed employing the ‘advanced relative quantification’ and ‘standard curve method’. A calibrator cDNA was included in each run to correct for run-to-run differences.

Chemicals and lipid standards for lipidomics

All solvents, reagents, and lipid standards were used in the highest available purity. Internal standards were acquired from Avanti Polar Lipids (Avanti Polar Lipids, Alabama, USA).

Storage solution was created by combining chloroform, methanol, and water (20/10/1.5; v/v/v). ESI spray mixture was created by combining chloroform, methanol with added 0.1% (wt/v) ammonia acetate and 2-propanol (1:2:4; v/v/v).

Lipid extraction

A customized methyl-tert-butyl ether (MTBE)-based lipid extraction method [28] was applied for BAL and lung tissue homogenates. Details can be found in the S1 Text. Lipid extracts were stored in a storage solution at -20°C until further usage. Cholesterol determination was performed as described earlier [29] (S1 Text).

Shotgun lipidomics measurements

Aliquots of 10 μL of the lipid extract and cholesterol derivatization were diluted in 190 μL ESI spray mixture for each measurement, vigorously mixed, and centrifuged prior to loading into a 96 well plate (Eppendorf, Hamburg, Germany). The well plate was sealed with aluminum sealing foil and kept at 15°C during the measurement process. All measurements were performed in duplicate. All mass spectrometric acquisitions were performed using a Triversa Nanomate (Advion, Ithaca, USA) as an autosampler and nano-ESI source, applying a spray voltage of 1.1 kV and backpressure of 1.1 psi in ionization modes. For the acquisition of tandem mass spectrometric data, a Q Exactive Plus was used (Thermo Fisher Scientific, Bremen, Germany; methodological details are found in the S1 Text).

Lipidomics data processing

For data interpretation, the software pipeline described earlier was utilized (see details S1 Text) [30]. Briefly, mass spectra raw files were converted to mzML format with the software module "msconvert" from ProteoWizard version 3.0.18212-6dd99b0f6 [31]. Converted files were then imported into LipidXplorer version 1.2.8.1 [32]. For each ESI mode, a different set of MFQL [33] files is used. The files generated in LipidXplorer were used in lxPostman for further post-processing, including quality control and quantitation. All details on how the lipidome data (S1 Data) was generated for visualization and statistical analysis is available at LIFS webportal https://lifs-tools.org/publications/99-shotgun-lipidomics-data-set-lamp3-is-critical-for-surfactant-homeostasis-in-mice.html

Statistical analysis for lipidomic data

Two-way ANOVA was performed with the parameters matching time points for each row, mixed-effects with full fitting, and within each row comparing columns with correcting for multiple comparisons via Tukey. Lipid values are expressed as mean ± standard deviation and significance is designated as *, P < 0.05; **, P < 0.01; ***, P < 0.001.

For easier visualization of significant lipid results, lipids from two-way ANOVA were autoscaled. In this procedure, data are centered on the means of groups and then divided by the standard deviation, removing the impact of differences between lipid abundance.

Bubble surfactometer

Cell free BAL was weighed (= 400–800 μl) and ultra-centrifuged (J2-MC, Beckman Coulter, Krefeld, Germany) for 1h at 4°C at 38,730 g. The supernatant was decanted. The pellet was weighed and resuspended using saline containing 1.5 mmol/L CaCL2 equivalent to a concentration of 1:50 (w/w) compared to the basic BAL. Two μl of the concentrated BAL were analyzed for content of choline-containing phospholipids (DPPC, lysolecithin, sphingomyelin; LabAssay Phospholipids, FUJIFILM WAKO). Then, samples were normalized to final phospholipids-, i.e. choline containing phospholipids-, concentration of 1.5 mg/ml and analyzed in the Pulsating Bubble Surfactometer [34]. A Pulsating Bubble Surfactometer -sample chamber was prefilled using degassed 10% sucrose in saline plus 1.5 mmol/l CaCL2. Then, 5 μl of each normalized BAL sample were pipetted on the top of the sucrose prefill close to the chimney, where it remained by buoyancy. Subsequently, to mounting of the chamber in the Pulsating Bubble Surfactometer, an air bubble was created by aspiration of ambient air through the chimney and phospholipids were allowed to adsorb for 30s to the air/liquid interface. Then, the bubble was cyclically expanded and compressed at a frequency of 20/min, a compression rate of 50% surface area and at 37° C. Surface tension at maximum (γmax) and minimum (γmin) bubble size was calculated by the Pulsating Bubble Surfactometer and recorded for a 300s period.

Statistical analyses. If not stated otherwise, a two-tailed unpaired t-test was performed using GraphPad Prism Software Version 5.03. Significant values were considered at P < 0.05. Values are expressed as mean ± standard error of the mean (SEM) and significance is designated as *, P < 0.05; **, P < 0.01; ***, P < 0.001. Single datapoints for plotting data are available as S2 Data.

Results

Lamp3 knockout mice are viable with normal lung anatomy and pulmonary function

LAMP3 is expressed highest in humans and mice in the lung’s AT2 cells, where it localizes to LBs [4,5]. Notably, a naturally occurring recessive missense LAMP3 variant has recently been associated with a fatal neonatal interstitial lung disease in Airedale Terrier dogs [24]. Therefore, we aimed to analyze the function of LAMP3 in the lung in a genetically more defined animal model and generated Lamp3 knockout mice (Lamp3-/-). CRISPR/Cas9 editing of the Lamp3 allele in mice with guide RNAs targeting exon 2 (Fig 1A and 1B) yielded a 40 bp deletion resulting in an early Stop-codon in one founder, and the mutation was transmitted in the germline (Fig 1C). PCR with primers spanning this deletion was used for genotyping (Fig 1D). Reverse transcriptase PCR and quantitative realtime PCR with total lung RNA as a template with primers specific for LAMP3 revealed a complete absence of LAMP3 transcript, indicating nonsense-mediated decay (Fig 1E and 1F). LAMP3 was readily detectable by immunohistochemistry on lung sections with a monoclonal antibody in AT2 cells of wildtype mice but was completely absent in Lamp3-/- mice, validating the knockout at the protein level (Fig 1G). We hypothesized that knockout of Lamp3 in mice causes abnormal surfactant homeostasis and postnatal death. However, in contrast to dogs with a LAMP3 mutation, homozygous Lamp3-/- mice were surprisingly born according to the expected Mendelian distribution and survived the weaning phase without increased mortality (Fig 1H). No premature death was observed until 15 months-of-age, indicating that LAMP3 is not essential for survival in mice. Macroscopically, Lamp3-/- mice were indistinguishable from wildtype littermates with no obvious phenotype. Histology and analysis of semi-thin sections revealed normal micro-anatomy of the lung with a typical distribution of AT2 cells, type I pneumocytes, alveolar macrophages, and regular capillaries (Fig 1I). Macroscopic signs of multifocal emphysema or edema (as previously described in dogs with a mutation in LAMP3, [24]) were absent in Lamp3-/- mice (Fig 1J). The lung volume, normalized to the body weight in 3-month-old animals, was comparable between wildtype and Lamp3-/- mice (Fig 1K).

[Figure omitted. See PDF.]

Fig 1. CRISPR/Cas9-mediated knockout of Lamp3 in mice.

(A) CRISPR guide-RNA sequences used for targeted editing of the murine Lamp3 allele. The Protospacer Adjacent Motif (PAM) is underlined. (B) Schematic drawing of CRISPR/Cas9-mediated targeting of exon 2 of the Lamp3 locus. (C) Sanger sequencing chromatogram of a PCR-product covering the targeted segment with genomic tail-DNA of one wild type and one homozygous Lamp3-/- mouse as a template. CRISPR target site one is underlined. The frameshift resulting from endogenous repair mechanisms results in an early stop codon. (D) Agarose gel with PCR-products of a PCR covering parts of exon 2 of the Lamp3 locus used for genotyping. (E) Representative agarose gel with the PCR products of reverse transcriptase reactions with total lung RNA as a template and primers specific for Lamp3 from two wildtype and two Lamp3-/- mice. (F) Quantitative real-time PCR of total RNA from wildtype and Lamp3-/- mice for LAMP3. The expression is was normalized to the housekeeping gene RPL32. n = 4 (per genotype); *** = p ≤ 0.001. (G) Immunohistochemistry staining of lung sections of wildtype and Lamp3-/- mice with an antibody specific for LAMP3. (H) Genotype distribution of the litters from heterozygote Lamp3+/—breeding pairs after weaning (3–4 weeks after birth). N = 208 individuals. (I) Left: Hematoxylin / Eosin staining of lung sections from adult wildtype and Lamp3-/- mice. Right: Toluidine blue staining of plastic-embedded semi-thin sections from adult wildtype and Lamp3-/- mice. (J) Photos of the inflated lungs of adult wildtype and Lamp3-/- mice. (K) Lung volume/body weight ratio of wild type and Lamp3-/- mice. n = 8 (per genotype), ns = not significant. (L) The number of inflammatory cells (lymphocytes, neutrophils, eosinophils, and macrophages) in the BAL of wildtype and Lamp3-/- mice. n = 8 (per genotype), ns = not significant; 0.05; * = p ≤ 0.05.

https://doi.org/10.1371/journal.pgen.1009619.g001

Furthermore, lung function analysis revealed no abnormalities in the breathing pattern of Lamp3-/- mice regarding the frequency, flow, volume, and time parameters as non-invasively assessed in spontaneously breathing animals as well as for airway resistance and compliance as recorded invasively in relaxed, ventilated animals (Table 1). Analysis of the BAL cellular composition revealed a tendency towards a higher number of lymphocytes and neutrophils in Lamp3-/- mice, which, however, did not reach statistical significance. The number of macrophages was moderately increased in Lamp3-/- mice (Fig 1L).

[Figure omitted. See PDF.]

Table 1. Steady state lung parameters in wildtype and Lamp3-/- mice.

Airway resistance (RI) and dynamic compliance were measured in anesthetized and ventilated mice using FinePointe RC Units. Midexpiratory flow (EF50), frequency (f), functional residual capacity (Frc), minute volume (MV), peak expiratory flow (PEF), peak inspiratory flow (PIF), expiration time (Te), inspiration time (Ti), and tidal volume (TV) were measured in conscious, spontaneously breathing mice using FinePointe non-invasive airway mechanics (NAM) double chamber plethysmography. Values displayed as mean ± SEM, n = 7 per genotype.

https://doi.org/10.1371/journal.pgen.1009619.t001

LAMP3 deficiency in mice causes changes in surfactant protein levels

We reasoned that a lack of LAMP3 might affect the levels of the surfactant proteins SP-B and SP-C, major components of the LB-stored- and secreted surfactant. Indeed, quantitative PCR analysis revealed reduced levels of Sftpb transcript and a similar trend (though not statistically significant) for Sftpc in total lung RNA (Fig 2A) of Lamp3 knockout mice. In contrast, immunoblot analysis of lung tissue lysates from wildtype and Lamp3-/- mice for SP-B and SP-C showed normal levels of pro-SP-B and a striking increase in the levels of pro-SP-C, the immature pro-form of SP-C, indicating a critical role of LAMP3 in the biosynthesis or turnover of SP-C (Fig 2B and 2C). The levels of mature SP-B were also significantly increased, though only to a moderate level compared to the increase in SP-C.

[Figure omitted. See PDF.]

Fig 2. LAMP3-deficiency results in altered (pro-)surfactant C levels.

(A) Quantitative real-time PCR of total RNA from wildtype and Lamp3-/- mice for SP-B and SP-C. The expression was normalized to the housekeeping gene RPL32. n = 8 (per genotype), ns = not significant; ** = p ≤ 0.01. (B) Representative immunoblots of lung tissue lysates from wildtype and Lamp3-/- mice for pro-SP-C, pro-SP-B, and mature SP-B. Actin is depicted as a loading control. (C) Quantification of immunoblots for pro-SP-C, pro-SP-B, and mature SP-B normalized to Actin as a loading control. The average of the wildtype group was set as “1”. n = 8 (per genotype); ns = not significant; *** = p ≤ 0.001. (D) Immunofluorescence staining of lung sections from adult wildtype and Lamp3-/- mice for ABCA3 and mature SP-B (green). Nuclei are stained with DAPI (blue).

https://doi.org/10.1371/journal.pgen.1009619.g002

Immunofluorescence analysis on lung sections from wildtype and Lamp3-/- mice revealed no major differences in the staining pattern of the essential LB proteins ABCA3 or mature SP-B. Both proteins localized in wildtype and Lamp3-/- mice to ring-like structures of AT2 cells, representing LBs as determined by high-resolution fluorescence microscopy (Fig 2D).

The lipid composition of the bronchoalveolar lavage is altered in Lamp3-/- mice

Given the apparent differences in SP-C levels and mature SP-B in protein extracts of lung tissue lysates, we next analyzed the lipid composition of the BAL and total lung homogenates by a semi-targeted shotgun lipidomics approach. After shotgun lipidomics, a total of 208 different lipid species in the BAL were quantified. We first determined if the two groups (wildtype and Lamp3-/- BAL lipids) could be separated by analyzing the lipidomics dataset by unsupervised principal component analysis (PCA) (Fig 3A). The apparent separation was characterized by increased PGs and LPG levels in the wildtype while SMs are increased in the Lamp3-/- mice. To gain better insight into the perturbations on the lipid species level, we further applied hierarchical clustering (Fig 3B). In conjunction with the PCA, wildtype and Lamp3-/- mouse BAL lipid profiles were clearly distinguished by the underlying Spearman Rank correlation. According to the genotype, the abundance of lipid species correlated for PG, LPG, and DAG, showing a relative increase in wildtype mice, which was also confirmed by statistical analysis for the selected indicated lipids species (Fig 3C). In contrast, PI and LPI were decreased in Lamp3-/- mice. Notably, PG is an essential component of the pulmonary surfactant, and as multiple lipids of the same class were affected, a disruption of the normal BAL physical properties is likely. In contrast to BAL’s lipid profiles, no statistical differences were identified between wild type and Lamp3-/- mice by lipidomic analysis of the perfused total lung tissue (S1A–S1C Fig). These findings, in summary, indicate that LAMP3 deficiency leads to subtle but statistically significant changes in the lipidome and particularly surfactant-relevant lipids of the BAL.

[Figure omitted. See PDF.]

Fig 3. Deficiency of LAMP3 results in minor changes in the BAL lipidome under basal conditions.

(A) Three-dimensional principal component analysis (PCA) loadings plot of the BAL lipidome of wild type (black) and Lamp3-/- (green) mice. Each point represents one individual animal. Arrows show the 10 lipid species with the strongest effect across all principal components. Ellipses show the 95% confidence interval of the group. PC1 to PC3 explain 65% of the variability in the data set. (B) Hierarchical clustering of 140 lipid species (of 208 after application of a 90% occupation threshold) identified in eight wild type and seven Lamp3-/- mice BAL fluid samples. Each row represents a lipid species and each column a sample. Red boxes indicate enlarged selections (C2) and (C3). (C1) The hierarchical clustered tree of sample groups correlates both groups into two major branches. (C2) The Upper selected segment of the HCA with 31 lipids shown with a relative decrease to wildtype mice. (C3) The lower selected segment of the HCA was shown with a relative increase of 7 lipids to the control. (D) Differences in the BAL lipidome of wild type and Lamp3-/- mice mutant using autoscaled ranges. Samples are color-coded according to their group, black for Lamp3+/+ and green for Lamp3-/- mice. Boxplots show the median with the interquartile range. Whiskers show maximum and minimum with outliers in the respective colors. Data is on the basis of mole percentage. Only lipid species are shown with a significant difference computed with a two-way ANOVA.

https://doi.org/10.1371/journal.pgen.1009619.g003

Lamp3 knockout leads to rare changes in the ultrastructure of lamellar bodies and altered biophysical properties of pulmonary surfactant

Defects in surfactant homeostasis are typically accompanied by a change of the ultrastructure of LBs [11,12,24]. This finding prompted the analysis of the Lamp3-/- lungs by transmission electron microscopy, focusing on LBs in the AT2 cells. Lamellar bodies from wildtype mice had the typical lamellar appearance (Fig 4A). In one of the three Lamp3-/- mice that were analyzed by transmission electron microscopy, conspicuous lamellar bodies could occasionally be observed within AT2 cells (Fig 4A). They consisted of several clews of lipid lamellae and seemingly homogenous areas that were surrounded by a common limiting membrane. At higher magnification, the homogenous areas also revealed lamellae that were not immediately obvious at lower magnification (Fig 4A). However, lamellar bodies in the other two animals had a regular appearance comparable to the wildtype. Accordingly, we tested the surfactant’s biophysical properties and functionality obtained from BAL of wildtype and Lamp3-/- mice to address any functional relevance of such morphological alterations. Surfactant samples were investigated during dynamic compression of an air bubble in a pulsating bubble [34]. The surface tension (γ) of wildtype and Lamp3-/- mice is summarized at minimum (γmin) (Fig 4B) and maximum (γmax) bubble size (Fig 4C). Surfactant standardized at a phospholipid concentration of 1.5 mg/ml of both wildtype and Lamp3-/- mice reached a low physiological γmin close to 0 mN/m during the observational period of 300s, respectively (Fig 4B). During the compression period, γmin (0.95 vs 3.6 mN/m, median, p<0.01) and γmax (29.2 vs. 29.9 mN/m, median, p<0.0001) in Lamp3-/- mice were found to be moderatly lower compared to wild type surfactant. Thus initially, γmin of samples from Lamp3-/- mice decreased faster, reaching <10 mN/m after 40s compared to wildtype surfactant after 80s (mean) (Fig 4C), indicating a slightly increased adsorption property of surfactant from Lamp3-/- mice.

[Figure omitted. See PDF.]

Fig 4. Deficiency of LAMP3 leads to altered LB morphology and reduced surfactant functionality.

(A) Transmission electron microscopy of LB in an alveolar AT2 cells of a wildtype and a Lamp3-/- mouse. Wildtype: Individual Lamellar Bodies are clearly discernible and separated (left), containing continuous lipid lamellae (right). Lamp3-/-: Left: Multiple clews of lipid lamellae (white asterisks) are located within shared limiting membranes (white arrowheads). The space between the clews (black asterisks) is entirely filled with light grey material. Right: enlargement of the boxed area indicated left. Higher magnification reveals lamellae also inside the light grey material, which in some cases obviously are continuations of the darker stained lamellae inside the clew (top) or the stack of lamellae bottom left. (B, C) Surface tension at minimum (γmin; C)) and maximum (γmax; B) bubble size, derived from a pulsating bubble surfactometer [34] during a pulsating period of 300s. Eight pellets of BAL from Lamp3-/- and wild type mice were prepared by ultracentrifugation and resuspended in saline CaCl2 to standardize phospholipids to 1.5 mg/ml each. Phospholipid concentration was determined using a commercial kit. Data are plotted as mean +/-SD. Statistical analysis was performed using an unpaired t-test.

https://doi.org/10.1371/journal.pgen.1009619.g004

Lamp3-/- mice show increased airway resistance and aggravated BAL lipid changes under pathological conditions

The overall phenotype of Lamp3-/- mice was mild and did not affect lung function to the extent that functional lung tests could reveal alterations in healthy, spontaneously breathing animals (Table 1). We, therefore, wondered if LAMP3 is more critical under challenged, i.e., pathological conditions. We applied a well-described model of experimental allergic asthma [25,35] (Fig 5A) that is characterized by impaired lung physiology arising on the basis of allergic airway inflammation, mucus hyperproduction, and airway hyperresponsiveness (AHR), but provides the advantage that LAMP3-expressing AT2 cells remain largely untouched by the induced disease. Analysis of the different immune-cell populations (macrophages, lymphocytes, neutrophils, eosinophils) infiltrating the bronchoalveolar lumen in diseased animals did not unveil any differences between wildtype and Lamp3-/- mice (Fig 5B). The number of mucus-producing goblet cells and the amount of mucus stored in the airway mucosa also did not differ (S3 Fig). The degree of apoptotic cell death as revealed by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining between wildtype and Lamp3-/- mice remained unchanged (S4 Fig). Remarkably, when animals were subjected to MCh-provocation testing to determine the degree of AHR, Lamp3-/- mice displayed significantly increased airway resistance in response to MCh-inhalation (Fig 5C). In contrast, baseline airway resistance values did not differ between OVA-sensitized and challenged wildtype and Lamp3-/- mice (S5 Fig).

[Figure omitted. See PDF.]

Fig 5. The allergen-induced asthma model aggravates phenotypes in Lamp3-/- mice and causes a genotype-dependent increase in airway resistance.

(A) Experimental setup of the stress-challenged model of allergic asthma and the experimental groups. (B) Number of inflammatory cells in the BAL of wildtype, Lamp3-/-, wildtype + OVA, Lamp3-/- +OVA mice. N = 8 (per genotype), ns = not significant; 0.05; * = p ≤ 0.05. (C) Increase in airway resistance relative to baseline (%) of the four experimental groups (wildtype, Lamp3-/-, wildtype + OVA, Lamp3-/- +OVA). N = 8 (per genotype), significances calculated for methacholine provocation test after 100 mg/ml methacholine exposure, ns = not significant; 0.05; **** = p ≤ 0.0001. (D) Two-dimensional PCA loadings plot of the BAL lipidome of wild type (black), Lamp3-/- (green), wild type +OVA (blue), and Lamp3-/- +OVA (red) mice. The datasets for wild type (black), Lamp3-/- (green) are identical to (Fig 3A). Each point represents one individual. Arrows show the 10 lipid species with the strongest effect on all principal components. Ellipses indicate the 95% confidence interval of the experimental groups, where PC1 and PC2 describe 48.9% of the variability in the data set. The separation of the groups is in PC1, and PC2 is not complete for all groups. A clear separation between the Lamp3+/+ +PBS and Lamp3+/+ +OVA can be seen. The separation between untreated Lamp3-/- and treated Lamp3-/- is not complete. (E) Hierarchical clustering of 140 lipid species (of 208 after application of a 90% occupation threshold) identified in 8 wild type +OVA and 8 Lamp3-/- +OVA mice BAL fluid samples. Each row represents a lipid species and each column a sample. Red boxes indicate selections shown in (F). The two major branches of the tree represent the genotypes without false assignments. Selected segments of the hierarchical clustered tree where a relative decrease for 21 lipids for Lamp3-/-, mainly DAG and PG species, compared to the Lamp3+/+ mice are observed. The lower selection shows, in contrast, a cluster of 26 lipids with a relative increase in quantity in the mutant compared to Lamp3+/+. (G) Differences in the BAL lipidome of wild type +OVA and Lamp3-/- +OVA applying autoscaling. Samples are color-coded according to their group, red for Lamp3+/+ +OVA and blue for Lamp3-/- +OVA. Boxplots show the median with the interquartile range, and whiskers show maximum and minimum with outliers in the respective colors. Data is based on mole percentage. Selected lipid species showed a significant difference by two-way ANOVA. (H) Bar plots of absolute lipid values normalized on protein content. Error bars signify standard deviations.

https://doi.org/10.1371/journal.pgen.1009619.g005

To further investigate the impact of experimental asthma in mice, the lipid composition of the BAL and total lung tissue was determined (Fig 5D–5G). The response to experimentally induced asthma led to further divergence in the BAL lipid composition between Lamp3-/- mice and wildtype. Further increases in PG, LPG, and DAG abundance were observed in wildtype mice while levels of SM and PI increased in Lamp3-/-. In the lipidomes of the perfused total lung tissue, no further changes were observed (S2 Fig). Hierarchical cluster analysis further revealed that the opposite response in the BAL lipidome of the wildtype and Lamp3-/- mice affected a wider range of lipid species, compared to the healthy animals (Figs 5E and 3B–3D). Spearman Rank correlation between the two distinct groups (wildtype and Lamp3-/-) further confirmed this lipid phenotype by high correlation factor for the two major branches comprising lipid compositions of 8 animals in each group (Fig 5F). Lipid species of mainly PG, LPG, and DAG classes showed a relative increase in Lamp3+/+ mice, which were statistically significant for indicated lipid species. In contrast, PI, LPE, Cer, and SM showed increased abundance in Lamp3-/- mice (Fig 5G). In summary, the lipid homeostasis for surfactant production in BAL of Lamp3-/- mice was more disturbed under the pathophysiologic conditions of experimental asthma when compared to the unchallenged animals.

Discussion

The two best-characterized family members of the LAMP family, LAMP1 and LAMP2, are ubiquitously expressed and quantitatively account for a substantial fraction of the lysosomal membrane proteome [21,36]. Though the function of LAMP1 and LAMP2 are still not fully understood, they are supposed to play pivotal roles in the fusion of membranes, autophagy, microtubule-dependent positioning of lysosomes, and especially as structural components of the lysosomal membrane [37]. In contrast, the expression of the structurally related LAMP3 protein is limited to specific cell types, implicating a more defined and tissue/cell-type-specific function. Together with the fact that LAMP3 localizes to LBs rather than lysosomes, a critical function of LAMP3 in LB function and surfactant homeostasis is suggested. In fact, the recent finding that a natural mutation (p.(E387K) in LAMP3 leads to clinical symptoms and pathology similar to the most severe neonatal forms of surfactant deficiency in an Airedale Terrier dog breed suggested a critical role in surfactant biology and lung physiology for LAMP3.

Therefore, we aimed to investigate the role of LAMP3 in lung physiology by using a genuine knockout model. To our surprise, our findings obtained from Lamp3-/- mice revealed striking differences to those found in dogs with the recessive missense LAMP3 variant: While lethal hypoxic respiratory distress and failure lead to the premature death of dog puppies within the first days or week of living [24], Lamp3-/- mice developed normally and did not display signs of lung pathology and dysfunction after birth. We can only speculate about the apparent difference between the different animal models: On the one hand, in contrast to laboratory mouse strains, dog breeds like the Airedale Terrier were generated by inbreeding that aimed to pronounce or produce distinct anatomical features. Thus, it could not be excluded that other genetic factors, possibly homozygous in the inbred dogs, impact this phenotype. On the other hand, the point mutation (p.(E387K)) found in the dogs resulted in the expression of a LAMP3 variant that could still be detected with a LAMP3-specific antibody in lung tissue [24], suggesting that the overall protein structure of the LAMP3 variant is at least in part untouched by the mutation. This finding leaves the possibility of an impaired function of the mutated variant, which is not the case when LAMP3 is completely knocked-out by CRISPR/Cas9. Another possibility potentially explaining the differences between the complete knockout and the point-mutation is genetic compensation, a process of transcriptional adaptation which acts independently of protein feedback loops [38]. While the knockout might lead to the upregulation of compensatory mechanisms, attenuating the phenotype in mice, the point mutation might not induce such compensatory pathways. These findings, however, should be considered when human patients suffering from surfactant deficiencies are analyzed: Our data suggest that LAMP3 mutations might also present with a mild clinical phenotype, perhaps not immediately presenting with the typical signs of a full surfactant deficiency in human patients suffering from childhood interstitial lung disease. Since neither snap-frozen tissue samples nor BAL from the affected Airedale Terrier puppies could be obtained, characterization of the phenotype caused by a mutation of the LAMP3 gene in dogs is quite limited in relation to the lipidome profile of BAL and the function of the surfactant.

The lipidomics analyses performed in this study are in good agreement with earlier reported quantities of main lipid species and classes by Prueitt et al. [16]. We find PC at 67.1 mol% in wildtype mice (16 mol% neutral lipids excluded as in study) compared to the previously reported 75.2 mol% [16]. The main contributing PC class lipid species is DPPC (PC 16:0/16:0) with 43.9% compared to the 30–60% reported in the literature [14,17,39,40]. PG was found at 9 mol% in agreement with the values reported by others [16]. Our analyses show a clear separation of the genotypes according to different lipid compositions and upon induction of experimental asthma. In the lipidomes of the perfused lung tissues, only minor Lamp3 genotype-dependent changes were observed, which underlines the importance of LAMP3 to regulate the lipid secretion in the surfactant. It is further noteworthy that the BAL lipid composition was mostly affected by the reduction in the abundance of PGs, LPG, and DAG in the Lamp3-/- mice. In transmission electron microscopy, phospholipids typically appear as bilayer lamellae, whereas neutral lipids typically form homogenous lipid droplets. Thus, the occurrence of conspicuous lamellar bodies in one out of three transgenic mice may indicate altered metabolism and/or trafficking of lipids in AT2 cells; however, the finding that LBs in the other two animals had a regular shape comparable to the wildtype puts this interpretation into perspective.

Remarkably, the alterations of the surfactant lipid and protein composition were not associated with pronounced changes of its adsorption properties, which even appeared to be slightly increased in Lamp3-/- mice. Indeed, this is quite in line with our findings on the lung structure and function of these mice under healthy conditions. Nevertheless, it does not exclude the possibility that an altered surfactant composition could have an impact on lung physiology under disease conditions, when the functional reserves of the respiratory system are exhausted. The altered lipid composition and particularly the increase in SP-C could cause enhanced adsorption of surfactant, and a more detailed functional analysis of surfactant is warranted.

Hence, experimentally induced asthma further reduced the levels of essential surfactant lipids and, in parallel, led to an increase in lipids like SM, PI, and PS. Interestingly lipids containing arachidonic acid (AA, FA 20:4) were elevated in Lamp3-/- mice. Further effects on signaling were not investigated in this study, although AA plays a crucial role as educt of numerous lipid mediators [41]. The increase in SM, PI and PS might indicate a higher degree of cell lysis in conjunction with increased number of immune cells in BAL after OVA treatment and an excessive immune reaction. However, it should be noted that we did not observe major differences in either the numbers, the numbers of apoptotic cells in lung tissues or infiltrating immune cells (e.g. eosinophils, lymphocytes, etc.) in BAL, which indicates that the sensitization and subsequent inflammation of the airways in reaction to allergen inhalation are not impacted by the knockout of Lamp3. In turn, these findings suggest that the changes in surfactant composition and its function give rise to an altered inflammatory response in the airways or eventually related apoptosis of cells.

While our data support a role of LAMP3 in surfactant homeostasis, we can only speculate about the mechanisms of how LAMP3 might regulate surfactant levels secreted by AT2 cells. Different scenarios are feasible: On the one hand, it has been speculated previously that LAMP3 plays a role in surfactant recycling by retrieving remnants of secreted LB via re-endocytosis [4]. On the other hand, other LAMP family members act as accessory subunits of multi-transmembrane spanning proteins like LAMP1/LAMP2 for the lysosomal polypeptide transporter TAPL [42]. Likewise, UNC-46, the C. elegans orthologue of LAMP5, acts as a trafficking chaperone, essential for the correct targeting of the nematode vesicular GABA-transporter UNC-47 [43]. LAMP3 could take over a similar function, e.g., by modulating or regulating the trafficking or stability of one of the integral LB proteins like SP-C (which is synthesized as a type II transmembrane protein).

Interestingly, the transcript-levels of Sftpb and Sftpc were significantly reduced or showed a trend towards a decrease, while protein levels were distinctively increased, suggesting posttranslational mechanisms governing the increased stability thereby leading to higher steady-state protein levels: a finding that could hint towards a stabilizing effect of LAMP3.However, such a mechanism might not be essential and become relevant only under conditions where surfactant levels need to be regulated more tightly. It is interesting to note that an aggravation of the lipid changes under the pathological conditions of experimental allergic asthma was associated with the lung function differences observed after MCh-provocation, when lung function was pushed to the limit. In sensitized animals, inhalation of allergen aerosols results in an acute inflammatory reaction with infiltration of T helper 2 (TH2) cells and eosinophils into the airways and the release of a plethora of cytokines, chemokines, and cytotoxic metabolites [35]. Consequently, this causes activation of submucosal glands and differentiation of goblet cells, ultimately resulting in increased mucus production. TH2-type cytokines, together with eosinophil products, trigger the development of AHR that leads to an increased airway resistance in response to non-allergic stimuli and the formation of the typical asthma attack [44]. Therefore, in mice with experimental allergic asthma, the degree of allergic airway inflammation is closely correlated with the degree of mucus production, and AHR. Remarkably, this was not the case in Lamp3-/- mice: Numbers of inflammatory cells such as eosinophils and lymphocytes as well as the number of goblet cells and amount of mucus stored in the airway mucosa are not different between wildtype and Lamp3-/- mice. The lack of any differences between Lamp3-/- and wildtype animals could be explained by the fact that the pathologic features of experimental allergic asthma are restricted to the airways, while the knock-out of Lamp3 affects AT2 cells, which are located in the alveoli, which remain largely untouched. Nevertheless Lamp3-/- mice displayed a markedly increased airway resistance in response to MCh inhalation. Since this response appeared to be independent of both the degree of airway inflammation and mucus production, respectively, it is possible that the increase in airway resistance was not compelling due to an increased AHR. Whether the alterations of the surfactant lipid and protein composition, which we found in healthy Lamp3-/- mice, could be causative for the observed impairment of lung function remains speculative. To our knowledge alteration of surfactant lipid or SP-B/C composition have not been connected to increased MCh-response of the airways yet, the surfactant film lining the alveoli and conducting airways has an impact on airway resistance. Hence, during expiration this film can develop high surface pressure and thus low surface tension, respectively, which in turn counteracts the tendency of liquid to accumulate in the airway’s most narrow section [45]. At this point, alterations of the surfactant composition may result in an increased liquid accumulation and consequently blocking of terminal airways, which further leads to an increased airway resistance.

Taken together, whereas the lack of LAMP3 appears to be compensable under physiological conditions, it impacts basal surfactant homeostasis and lung lipid composition and airway resistance in experimental allergic asthma.

Supporting information

S1 Text. Supplementary methods.

https://doi.org/10.1371/journal.pgen.1009619.s001

(DOCX)

S1 Fig. Deficiency of LAMP3 results in no observable changes in the lipidome composition under basal conditions.

(A) Two-dimensional principal component analysis (PCA) loadings plot of the BAL lipidome of wild type (black) and Lamp3-/- (green) mice. Each point represents one individual animal. Ellipses show the 95% confidence interval of the group. PC1 and PC2 explain 54.1% of the variability in the data set. Confidence intervals show a complete overlapping of samples belonging to both groups. Both groups are not separated by PCA. (B) Hierarchical clustering of 158 lipid species (of 393 after application of 90% occupation threshold) identified in eight wildtype and eight Lamp3-/- mice lung tissue samples. Each row represents a lipid species and each column a sample. (C) The hierarchical clustered tree of sample groups is not able to correlate both samples into two distinct branches.

https://doi.org/10.1371/journal.pgen.1009619.s002

(PDF)

S2 Fig. Deficiency of LAMP3 results in no observable differences in the lipidome composition when inducing the allergic asthma model.

(A) Two-dimensional principal component analysis (PCA) loadings plot of the BAL lipidome of wild type (blue) and Lamp3-/- (red) mice. Each point represents one individual animal. Ellipses show the 95% confidence interval of the group. PC1 and PC2 explain 53.6% of the variability in the data set. Confidence intervals show a complete overlapping of samples belonging to both groups. No separation of samples into two distinct groups is performed by PCA. (B) Hierarchical clustering of 237 lipid species (of 394 after a threshold of 90% occupation was applied) identified in eight wildtype and seven Lamp3-/- mice lung tissue samples. Each row represents a lipid species and each column a sample. (C) The hierarchical clustering analysis clusters samples into multiple branches not correlating to the distinct groups.

https://doi.org/10.1371/journal.pgen.1009619.s003

(PDF)

S3 Fig. Mucus production is not altered in Lamp3-/- mice with or without OVA.

Quantification of mucus production in airway epithelial cells. OVA-induced experimental asthma increases mucus production. Lamp3-/- phenotype does not alter the amount and distribution of cells stained positive for mucus. Area of epithelial basal membrane covered by goblet cells (A), stored mucus volume per basal membrane area (B), and mucus stored per goblet cell (C). A-C: n = 8 mice per group.

https://doi.org/10.1371/journal.pgen.1009619.s004

(PDF)

S4 Fig. Apoptosis is not altered in Lamp3-/- mice with or without OVA.

Apoptosis staining (TUNEL assay) of inflated formalin-fixed paraffin embedded crosssections of the lung. Lamp3-/- phenotype does not alter the amount and distribution of cells stained positive for apoptosis (brown staining). Representative staining of healthy wildtype (upper left), healthy knockout Lamp3-/- (lower left), asthmatic wildtype (upper right), and asthmatic knockout Lamp3-/- (lower right).

https://doi.org/10.1371/journal.pgen.1009619.s005

(PDF)

S5 Fig. Airway hyper-responsiveness in allergic asthma model is aggravated in Lamp3-/- mice.

Increase in airway resistance of the four experimental groups (wildtype, Lamp3-/-, wildtype + OVA, Lamp3-/- + OVA). N = 8 (per genotype) in absolute values, significances calculated for methacholine provocation test after 100 mg/ml methacholine exposure, ns = not significant; 0.05; **** = p ≤ 0.0001.

https://doi.org/10.1371/journal.pgen.1009619.s006

(PDF)

S1 Data. Raw data of the lipidomics experiments including sample identifiers.

https://doi.org/10.1371/journal.pgen.1009619.s007

(XLSX)

S2 Data. All raw data and single values used for plotting data for the figures.

https://doi.org/10.1371/journal.pgen.1009619.s008

(XLSX)

Acknowledgments

We thank Gabriele Walter, Maike Langer, Linda Lang, Juliane Artelt, Franziska Beyersdorf, and Dominika Biedziak for excellent technical assistance. We thank Dr. Nils Hoffmann (ISAS Dortmund) for support in data upload and data base management of the LIFS webportal.

Citation: Lunding LP, Krause D, Stichtenoth G, Stamme C, Lauterbach N, Hegermann J, et al. (2021) LAMP3 deficiency affects surfactant homeostasis in mice. PLoS Genet 17(6): e1009619. https://doi.org/10.1371/journal.pgen.1009619

References

1. Furuta K, Yang XL, Chen JS, Hamilton SR, August JT (1999) Differential expression of the lysosome-associated membrane proteins in normal human tissues. Archives of biochemistry and biophysics 365: 75–82. pmid:10222041

2. Holness CL, Simmons DL (1993) Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81: 1607–1613. pmid:7680921

3. Tiveron MC, Beurrier C, Ceni C, Andriambao N, Combes A, et al. (2016) LAMP5 Fine-Tunes GABAergic Synaptic Transmission in Defined Circuits of the Mouse Brain. PloS one 11: e0157052. pmid:27272053

4. Salaun B, de Saint-Vis B, Pacheco N, Pacheco Y, Riesler A, et al. (2004) CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytes. The American journal of pathology 164: 861–871. pmid:14982840

5. Akasaki K, Nakamura N, Tsukui N, Yokota S, Murata S, et al. (2004) Human dendritic cell lysosome-associated membrane protein expressed in lung type II pneumocytes. Archives of biochemistry and biophysics 425: 147–157. pmid:15111122

6. de Saint-Vis B, Vincent J, Vandenabeele S, Vanbervliet B, Pin JJ, et al. (1998) A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 9: 325–336. pmid:9768752

7. Salaun B, de Saint-Vis B, Clair-Moninot V, Pin JJ, Barthelemy-Dubois C, et al. (2003) Cloning and characterization of the mouse homologue of the human dendritic cell maturation marker CD208/DC-LAMP. European journal of immunology 33: 2619–2629. pmid:12938238

8. Veldhuizen EJ, Haagsman HP (2000) Role of pulmonary surfactant components in surface film formation and dynamics. Biochimica et biophysica acta 1467: 255–270. pmid:11030586

9. Nogee LM, de Mello DE, Dehner LP, Colten HR (1993) Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. The New England journal of medicine 328: 406–410. pmid:8421459

10. Nogee LM, Dunbar AE, 3rd, Wert SE, Askin F, Hamvas A, et al. (2001) A mutation in the surfactant protein C gene associated with familial interstitial lung disease. The New England journal of medicine 344: 573–579. pmid:11207353

11. Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, et al. (1995) Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proceedings of the National Academy of Sciences of the United States of America 92: 7794–7798. pmid:7644495

12. Glasser SW, Burhans MS, Korfhagen TR, Na CL, Sly PD, et al. (2001) Altered stability of pulmonary surfactant in SP-C-deficient mice. Proceedings of the National Academy of Sciences of the United States of America 98: 6366–6371. pmid:11344267

13. Yu S, Harding PGR, Smith N, Possmayer F (1983) Bovine Pulmonary Surfactant—Chemical-Composition and Physical-Properties. Lipids 18: 522–529. pmid:6688646

14. Kahn MC, Anderson GJ, Anyan WR, Hall SB (1995) Phosphatidylcholine Molecular-Species of Calf Lung Surfactant. American Journal of Physiology-Lung Cellular and Molecular Physiology 269: L567–L573. pmid:7491974

15. Agudelo CW, Kumley BK, Area-Gomez E, Xu YM, Dabo AJ, et al. (2020) Decreased surfactant lipids correlate with lung function in chronic obstructive pulmonary disease (COPD). PloS one 15. pmid:32027677

16. Prueitt JL, Chi EY, Lagunoff D (1978) Pulmonary Surface-Active Materials in Chediak-Higashi-Syndrome. Journal of lipid research 19: 410–415. pmid:580786

17. Postle AD, Heeley EL, Wilton DC (2001) A comparison of the molecular species compositions of mammalian lung surfactant phospholipids. Comparative Biochemistry and Physiology a-Molecular and Integrative Physiology 129: 65–73. pmid:11369534

18. Lopez-Rodriguez E, Perez-Gil J (2014) Structure-function relationships in pulmonary surfactant membranes: from biophysics to therapy. Biochimica et biophysica acta 1838: 1568–1585. pmid:24525076

19. Arbibe L, Koumanov K, Vial D, Rougeot C, Faure G, et al. (1998) Generation of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interaction. Journal of Clinical Investigation 102: 1152–1160. pmid:9739049

20. Fitzgerald ML, Xavier R, Haley KJ, Welti R, Goss JL, et al. (2007) ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol. Journal of lipid research 48: 621–632. pmid:17142808

21. Chen JW, Pan W, D’Souza MP, August JT (1985) Lysosome-associated membrane proteins: characterization of LAMP-1 of macrophage P388 and mouse embryo 3T3 cultured cells. Archives of biochemistry and biophysics 239: 574–586. pmid:3923938

22. Shulenin S, Nogee LM, Annilo T, Wert SE, Whitsett JA, et al. (2004) ABCA3 gene mutations in newborns with fatal surfactant deficiency. The New England journal of medicine 350: 1296–1303. pmid:15044640

23. Somaschini M, Nogee LM, Sassi I, Danhaive O, Presi S, et al. (2007) Unexplained neonatal respiratory distress due to congenital surfactant deficiency. The Journal of pediatrics 150: 649–653, 653 e641. pmid:17517255

24. Dillard KJ, Ochs M, Niskanen JE, Arumilli M, Donner J, et al. (2020) Recessive missense LAMP3 variant associated with defect in lamellar body biogenesis and fatal neonatal interstitial lung disease in dogs. PLoS genetics 16: e1008651. pmid:32150563

25. Webering S, Lunding LP, Vock C, Schroder A, Gaede KI, et al. (2019) The alpha-melanocyte-stimulating hormone acts as a local immune homeostasis factor in experimental allergic asthma. Clinical and experimental allergy: journal of the British Society for Allergy and Clinical Immunology 49: 1026–1039.

26. Reynolds ES (1963) The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. The Journal of cell biology 17: 208–212. pmid:13986422

27. Lunding LP, Webering S, Vock C, Behrends J, Wagner C, et al. (2015) Poly(inosinic-cytidylic) acid-triggered exacerbation of experimental asthma depends on IL-17A produced by NK cells. Journal of immunology 194: 5615–5625. pmid:25972482

28. Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D (2008) Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. Journal of lipid research 49: 1137–1146. pmid:18281723

29. Liebisch G, Binder M, Schifferer R, Langmann T, Schulz B, et al. (2006) High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). Biochimica Et Biophysica Acta-Molecular and Cell Biology of Lipids 1761: 121–128. pmid:16458590

30. Schwudke D, Shevchenko A, Hoffmann N, Ahrends R (2017) Lipidomics informatics for life-science. Journal of biotechnology 261: 131–136. pmid:28822794

31. Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, et al. (2012) A cross-platform toolkit for mass spectrometry and proteomics. Nature Biotechnology 30: 918–920. pmid:23051804

32. Herzog R, Schuhmann K, Schwudke D, Sampaio JL, Bornstein SR, et al. (2012) LipidXplorer: A Software for Consensual Cross-Platform Lipidomics. PloS one 7. pmid:22272252

33. Herzog R, Schwudke D, Schuhmann K, Sampaio JL, Bornstein SR, et al. (2011) A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language. Genome biology 12. pmid:21247462

34. Enhorning G (1977) Pulsating bubble technique for evaluating pulmonary surfactant. Journal of applied physiology: respiratory, environmental and exercise physiology 43: 198–203. pmid:578145

35. Lunding L, Webering S, Vock C, Schroder A, Raedler D, et al. (2015) IL-37 requires IL-18Ralpha and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice. Allergy 70: 366–373. pmid:25557042

36. Wilke S, Krausze J, Bussow K (2012) Crystal structure of the conserved domain of the DC lysosomal associated membrane protein: implications for the lysosomal glycocalyx. BMC biology 10: 62. pmid:22809326

37. Eskelinen EL, Tanaka Y, Saftig P (2003) At the acidic edge: emerging functions for lysosomal membrane proteins. Trends in cell biology 13: 137–145. pmid:12628346

38. El-Brolosy MA, Stainier DYR (2017) Genetic compensation: A phenomenon in search of mechanisms. PLoS genetics 13: e1006780. pmid:28704371

39. King RJ (1982) Pulmonary Surfactant. Journal of applied physiology 53: 1–8. pmid:6749772

40. Holm BA, Wang ZD, Egan EA, Notter RH (1996) Content of dipalmitoyl phosphatidylcholine in lung surfactant: Ramifications for surface activity. Pediatric Research 39: 805–811. pmid:8726232

41. Bennett M, Gilroy DW (2016) Lipid Mediators in Inflammation. Microbiology spectrum 4. pmid:27837747

42. Demirel O, Jan I, Wolters D, Blanz J, Saftig P, et al. (2012) The lysosomal polypeptide transporter TAPL is stabilized by interaction with LAMP-1 and LAMP-2. Journal of cell science 125: 4230–4240. pmid:22641697

43. Schuske K, Palfreyman MT, Watanabe S, Jorgensen EM (2007) UNC-46 is required for trafficking of the vesicular GABA transporter. Nature neuroscience 10: 846–853. pmid:17558401

44. Wegmann M (2009) Th2 cells as targets for therapeutic intervention in allergic bronchial asthma. Expert Review of Molecular Diagnostics 9: 85–100. pmid:19099351

45. Enhorning G (2001) Pulmonary surfactant function studied with the pulsating bubble surfactometer (PBS) and the capillary surfactometer (CS). Comparative biochemistry and physiology Part A, Molecular & integrative physiology 129: 221–226.